Pfizer (NYSE: PFE) was on top of the world when it came to earnings and stock price performance. This was in early pandemic ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

This was the stock's third consecutive day of losses.

Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Pfizer (PFE) ended the recent trading session at $25.35, demonstrating a -1.17% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.14%.

Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company ...

Value stocks are generally companies that trade at a price lower than their fundamental value or what their performance ...

Over 50 listed companies including Sun Pharma, Mphasis, Pfizer, Veedol, Dr Reddy's Laboratories have announced final ...

WCM Investment Management increased its Pfizer holdings by 8.7% in Q1, snagging an extra 10,051 shares worth $3.17 million.

Pfizer Inc. shares fell 2% Tuesday despite the drugmaker topping Wall Street’s revenue and profit estimates in its fourth-quarter results.